From GMP manufacture of CellThRPE1 to regulatory authorisation of a First-in-Human Phase I clinical trial in geographic atrophy. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X26002405?dgcid=rss_sd_all
From GMP manufacture of CellThRPE1 to regulatory authorisation of a First-in-Human Phase I clinical trial in geographic atrophy. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X26002405?dgcid=rss_sd_all
“From GMP manufacture of CellThRPE1 to regulatory authorisation of a First-in-Human Phase I clinical trial in geographic atrophy.” Molecular Therapy Advances.
@article{article59083,
title = {From GMP manufacture of CellThRPE1 to regulatory authorisation of a First-in-Human Phase I clinical trial in geographic atrophy},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X26002405?dgcid=rss_sd_all}
}